Zoeken
Zoeken kan via de modus 'eenvoudig zoeken' (één veld) of uitgebreid via 'geavanceerd zoeken' (meerdere velden). Zo kan je bv. zoeken op een combinatie van een auteursnaam (auteur), een jaartal (jaar) en een documenttype.
Boekenmand
Nuttige resultaten kan je aanvinken en toevoegen aan een mandje. De inhoud hiervan kan je exporteren of afdrukken (naar bv. PDF).
RSS
Op de hoogte blijven van nieuw toegevoegde publicaties binnen uw interessegebied? Dit kan door een RSS-feed (?) te maken van jouw zoekopdracht.
nieuwe zoekopdracht
Marine bioresource development - Stakeholder's challenges, implementable actions, and business models
Collins, J.E.; Vanagt, T.; Huys, I.; Vieira, H. (2020). Marine bioresource development - Stakeholder's challenges, implementable actions, and business models. Front. Mar. Sci. 7: 62. https://dx.doi.org/10.3389/fmars.2020.00062
In: Frontiers in Marine Science. Frontiers Media: Lausanne. ISSN 2296-7745; e-ISSN 2296-7745, meer
Is gerelateerd aan:Collins, J.E.; Vanagt, T.; Huys, I.; Vieira, H. (2020). Corrigendum: Marine bioresource development - Stakeholder's challenges, implementable actions, and business models. Front. Mar. Sci. 7: 158. https://dx.doi.org/10.3389/fmars.2020.00158, meer
|   |
| Trefwoord |
|
| Author keywords |
marine biological resources; blue bioeconomy; blue biotechnology;business models; value chain; market; biodiversity; supply andtechnology |
| Auteurs | | Top |
- Collins, J.E.
- Vanagt, T.
- Huys, I.
- Vieira, H.
|
|
|
| Abstract |
Growth of the blue bioeconomy has potential for contributing positively toward economic growth, societal needs and multiple United Nations Sustainable Development Goals. However, organizations currently experience many challenges which limit success in this field. The aim of this paper is to identify trends in challenges linked to target end markets, stages in the value chain and organization types, to suggest potential solutions and link these to potential novel business models. A survey was completed by 58 organizations representing countries across four continents, and interviews were conducted with seven selected European start-ups/SMEs, to gather information regarding existing bottlenecks and to validate their business model. Results indicate that organizations targeting the pharmaceutical and nutraceutical sector experience a majority of challenges related to supply and technology, whereas organizations targeting the industrial biotechnology or agricultural industry experience more issues linked to market. Both bottom-up and top-down approaches could be applied in order to implement suggested actions. Analysis of the business model canvas used by start-ups/SMEs revealed potential for improvement. In particular, it was noted that review of the 'revenue stream' segment within the business model, specifically regarding alternatives to governmental funding, could be helpful for the long-term survival of these types of organizations. |
IMIS is ontwikkeld en wordt gehost door het VLIZ.
